First in serie of trying to evaluate the risk to reward ratio of supplementing and pharmacologically using omega-3 fatty acids to reduce disease risk
Conflicting clinical outcomes on the pharmacological use of omega-3s for reducing the risk of adverse cardiovascular events
Conflicting clinical outcomes on the…
Conflicting clinical outcomes on the pharmacological use of omega-3s for reducing the risk of adverse cardiovascular events
First in serie of trying to evaluate the risk to reward ratio of supplementing and pharmacologically using omega-3 fatty acids to reduce disease risk